Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,093 | -13,239 | -13,562 | -6,180 | -5,495 |
| Depreciation Amortization | 133 | 1,758 | 1,546 | 357 | 363 |
| Other Working Capital | 1,386 | -569 | 259 | 274 | -266 |
| Other Operating Activity | 880 | 608 | 737 | -2,732 | -2,815 |
| Operating Cash Flow | $-11,694 | $-11,442 | $-11,020 | $-8,282 | $-8,213 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -330 | -347 | -72 | -59 |
| Investing Cash Flow | $-25 | $-330 | $-347 | $-72 | $-59 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | -3 | -89 | -246 | -123 |
| Common Stock Issued | 9,025 | N/A | 7,869 | 13,016 | 3,300 |
| Other Financing Activity | 0 | 15,024 | 2,149 | 3,172 | -471 |
| Financing Cash Flow | $9,022 | $15,021 | $9,929 | $15,941 | $2,707 |
| Beginning Cash Position | 13,311 | 10,061 | 11,500 | 3,913 | 9,423 |
| End Cash Position | 10,615 | 13,311 | 10,061 | 11,500 | 3,858 |
| Net Cash Flow | $-2,696 | $3,249 | $-1,438 | $7,587 | $-5,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,694 | -11,442 | -11,020 | -8,282 | -8,213 |
| Capital Expenditure | -25 | -385 | -347 | -72 | -59 |
| Free Cash Flow | -11,718 | -11,827 | -11,367 | -8,355 | -8,272 |